体指数与多发性硬化症患者的残疾和认知表现相关:系统性审查和元分析
Farinaz Tabibian1, Elahe Hoseini2, Ali Motahharynia1
1Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Multiple sclerosis and related disorders
|June 26, 2025
概括
体 (CC) 的体积和面积是多发性硬化症 (MS) 的关键生物标志物. 规范化的CCV和CCA最好与残疾和认知功能相关,分别有助于疾病监测.
科学领域:
- 神经成像是一种神经成像.
- 神经学 神经学
- 生物标志物 生物标志物
背景情况:
- 体 (CC) 是多发性硬化症 (MS) 的关键生物标志物.
- CC体积 (CCV) 和CC面积 (CCA) 指数与残疾和认知功能相关.
- 在理解MS现象类型之间的这些关联方面存在差异.
研究的目的:
- 系统地综合有关CC指数与MS临床结果之间的相关性证据.
- 为了比较不同CC指数 (CCV,CCA) 与残疾 (EDSS) 和认知 (SDMT) 的关联强度.
- 探索影响这些关联的因素,包括年龄,MS表型和疾病持续时间.
主要方法:
- 系统的文献搜索与MS患者的临床结果相关联的CC大小/体积研究.
- 用随机效应模型在三项或更多项研究中报告的相关性 (r) 的元分析.
- 评估偏见风险,报告偏见和证据确定性.
- 亚组分析和元回归来研究异质性.
主要成果:
- 在整体多发性硬化患者群中,正常化CCV (nCCV) 和正常化CCA (nCCA) 是EDSS (r = -0.383) 和SDMT (r = 0.600) 的最强相关系.
- nCCA-EDSS相关性是根据年龄调节的,在复发性复发性多发性硬化症 (RRMS) 中不存在.
- 在RRMS中,nCCV与EDSS相关 (r = -0.429),在渐进性MS中与SDMT相关,因疾病持续时间增强.
结论:
- CC指数,特别是nCCV和nCCA,显示出与MS患者的残疾和认知表现有显著的相关性.
- CC指数的预测值因MS表型和临床结果而异.
- 这些发现凸显了CC指数作为监测MS进展和影响的有价值工具的潜力.
更多相关视频
07:30Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
3.1K
08:53Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
Published on: June 6, 2025
623
相关概念视频
Cerebral Hemispheres
3.8K
The human brain, a complex organ, is functionally divided into two cerebral hemispheres—left and right. These hemispheres are interconnected by a structure of paramount importance, the corpus callosum. This substantial bundle of neural fibers is not just a bridge between the hemispheres but a crucial element for the brain's comprehensive functioning. It enables efficient communication between the two hemispheres, allowing each side of the brain to control and receive sensory and motor...
3.8K
Multiple Sclerosis l: Introduction
20
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20
